Latest round: Growth. Fabrice Chouraqui is the CEO of Pharming Group N.V., a company that acquired Abliva AB. Based in Leiden, The Netherlands.
Fabrice Chouraqui is the CEO of Pharming Group N.V., a company that acquired Abliva AB. Under his leadership, Pharming Group reported a 42% increase in total revenues to US$79.1 million in Q1 2025. The company's products include RUCONEST and Joenja, and it is preparing for U.S. FDA approval for pediatrics in Q3 2025.
Full founder directory · Investor directory · Company funding database · Fundraising library